BMO Capital upgraded Extendicare (EXETF) to Outperform from Market Perform with a price target of C$24, up from C$21, after resuming coverage of the name. The company’s acquisition of CBI Home Health accelerates its shift towards service-based businesses, which should be structural winners in the coming years, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF: